Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marie-Agnes Lassoie is active.

Publication


Featured researches published by Marie-Agnes Lassoie.


Letters in Peptide Science | 1995

Bioactive conformations of peptides and mimetics as milestones in drug design: Investigation of NK1 receptor antagonists

Solo Goldstein; Michel Neuwels; Florence Moureau; Didier Berckmans; Marie-Agnes Lassoie; Edmond Differding; Raymond Houssin; Jean-Pierre Hénichart

Nine potent and selective substance P receptor antagonists (NK1 -) were analyzed with respect to their conformational space, with the aim to suggest probable conformations adopted at the receptor site and superposition rules for each structure (pharmacophore mapping). Key atoms within the ligands as well as receptor site points were considered in order to identify acceptable solutions (DISCO program). The results obtained allowed the suggestion or probable peptidic pharmacophores based on the structure of 1 (FK888). This knowledge was used to search commercial databases. The number and diversity of known retrieved NK1 antagonists allowed a general evaluation of the proposed pharmacophores. Moreover, a search in our proprietary database detected a short peptide with modest affinity but high selectivity for the NK1 receptor. The combination of molecular modeling with database searches is useful in a strategy aiming to develop new NK1 antagonists starting from existing knowledge.


Bioorganic & Medicinal Chemistry Letters | 2003

Discovery of orally bioavailable NK1 receptor antagonists

Christophe Genicot; Bernard Christophe; Philippe Collart; Michel Gillard; Laurence Goossens; Jean-Pierre Hénichart; Marie-Agnes Lassoie; F. Moureau; M. Neuwels; Jean-Marie Nicolas; Patrick Pasau; Luc Quere; Thomas Ryckmans; F. Stiernet; T. Taverne; B.J. Van Keulen

Benzyloxyphenethylpiperazines are a new class of high affinity NK1 receptor antagonists. Oral bioavailability and selectivity can be fine tuned by the nature of the substituents on the basic nitrogen atom. Addition of substituents with a carboxylic acid group led to very selective and orally active NK1 antagonists free of interaction with L-type calcium channels.


Bioorganic & Medicinal Chemistry Letters | 2001

N-Aminoindoline derivatives as inhibitors of 5-lipoxygenase.

Corinne Audouin; Nathalie Mestdagh; Marie-Agnes Lassoie; Raymond Houssin; Jean-Pierre Hénichart

N-Aminoindoline derivatives were prepared and their 5-lipoxygenase inhibitory activities were evaluated in vitro and compared with those of phenidone and NDGA. Compound 4 presents the most effective 5-LO inhibition.


Archive | 2003

2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors

Marie-Agnes Lassoie; Laurent Knerr; Thierry Demaude; Françoise de Laveleye-Defais; Thierry Kogej; Luc Quere; Sylvain Routier; Gerald Guillaumet


Archive | 2000

Compounds and methods for treatment of asthma, allergy and inflammatory disorders

Ralph Scannell; Pierre Chatelain; Anna Toy-Palmer; Edmond Differding; James L. Ellis; Marie-Agnes Lassoie; Michelle Young; Xiong Cai; Sajjat Hussoin; Gurmit Grewal; Tim Lewis


Archive | 2000

Alpha-arylethylpiperazine derivatives as neurokinin antagonists

Françoise Stiernet; Christophe Genicot; Marie-Agnes Lassoie; Florence Moureau; Thomas Ryckmans; Thierry Taverne; Jean-Pierre Henichart; Michel Neuwels; Solo Goldstein


Archive | 2008

2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF VLA-4 DEPENDENT DISEASES

Marie-Agnes Lassoie; Laurent Knerr; Thierry Demaude; Françoise de Laveleye-Defais; Thierry Kogej; Sylvain Routier; Gerald Guillaumet; Luc Quere


Archive | 2003

2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten 2,6-quinolinyl and 2,6-naphthyl derivatives and uses thereof for the treatment of VLA-4-related diseases

Marie-Agnes Lassoie; Laurent Knerr; Thierry Demaude; Laveleye-Defais Francoise De; Thierry Kogej; Sylvain Routier; Gerald Guillaumet; Luc Quere


Archive | 2000

Derives d'alpha-arylethylpiperazine utilises en tant qu'antagonistes de la neurokinine

Françoise Stiernet; Christophe Genicot; Marie-Agnes Lassoie; Florence Moureau; Thomas Ryckmans; Thierry Taverne; Jean-Pierre Henichart; Michel Neuwels; Solo Goldstein


Archive | 2000

Verbindungen und verfahren zur behandlung von asthma, allergie und entzündlichen erkrankungen Compounds and methods for treating asthma, allergy and inflammatory diseases

Ralph Scannell; Pierre Chatelain; Anna Toy-Palmer; Edmond Differding; James L. Ellis; Marie-Agnes Lassoie; Michelle Young; Xiong Cai; Sajjat Hussoin; Gurmit Grewal; Tim Lewis

Collaboration


Dive into the Marie-Agnes Lassoie's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sajjat Hussoin

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xiong Cai

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge